Fowler Alexander W, Gilbertie Jessica M, Watson Victoria E, Prange Timo, Osborne Jason A, Schnabel Lauren V
Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina.
Comparative Medicine Institute, North Carolina State University, Raleigh, North Carolina.
Vet Surg. 2019 Nov;48(8):1416-1428. doi: 10.1111/vsu.13304. Epub 2019 Aug 6.
To characterize the growth factors contained in equine amniotic membrane allograft (eAM; StemWrap scaffold and StemWrap+ injection) and to evaluate the effect of eAM on equine distal limb wound healing.
Prospective experimental controlled study.
Eight adult horses.
Transforming growth factor (TGF)-β1, vascular endothelial growth factor (VEGF), epidermal growth factor, platelet-derived growth factor-BB, and prostaglandin E (PGE ) concentrations in StemWrap+ were assessed with enzyme-linked immunosorbent assay. Two full-thickness 6.25-cm skin wounds were created on each metacarpus. On one forelimb, one wound was treated with eAM, and the other was left untreated (eAM control). On the contralateral limb, one wound was treated with a silicone dressing, and the other served as negative control. Three-dimensional images were obtained to determine wound circumference and surface area analyses at each bandage change until healed. Excessive granulation tissue was debrided once weekly for 4 weeks. Biopsy samples were taken to evaluate quality of wound healing via histologic and immunohistochemistry assays.
StemWrap+ contained moderate concentrations of TGF-β1 (494.10 pg/mL), VEGF (212.52 pg/mL), and PGE (1811.61 pg/mL). Treatment of wounds with eAM did not affect time to healing or histologic quality of the healing compared with other groups but was associated with increased granulation tissue production early in the study, particularly on day 7.
Application of eAM resulted in increased granulation tissue production while maintaining appropriate healing of experimental wounds.
Use of eAM is likely most beneficial for substantial wounds in which expedient production of large amounts of granulation tissue is desirable.
鉴定马羊膜同种异体移植物(eAM;StemWrap支架和StemWrap+注射液)中所含的生长因子,并评估eAM对马远端肢体伤口愈合的影响。
前瞻性实验对照研究。
八匹成年马。
采用酶联免疫吸附测定法评估StemWrap+中转化生长因子(TGF)-β1、血管内皮生长因子(VEGF)、表皮生长因子、血小板衍生生长因子-BB和前列腺素E(PGE)的浓度。在每只掌骨上制造两个6.25厘米的全层皮肤伤口。在一侧前肢,一个伤口用eAM治疗,另一个不治疗(eAM对照)。在对侧肢体,一个伤口用硅胶敷料治疗,另一个作为阴性对照。在每次更换绷带时获取三维图像,以确定伤口周长和表面积分析,直至伤口愈合。连续4周每周对过度增生的肉芽组织进行一次清创。通过组织学和免疫组织化学分析采集活检样本,以评估伤口愈合质量。
StemWrap+含有中等浓度的TGF-β1(494.10 pg/mL)、VEGF(212.52 pg/mL)和PGE(1811.61 pg/mL)。与其他组相比,用eAM治疗伤口不影响愈合时间或愈合的组织学质量,但在研究早期,尤其是第7天,与肉芽组织生成增加有关。
应用eAM可增加肉芽组织生成,同时保持实验伤口的适当愈合。
eAM的使用可能对需要快速产生大量肉芽组织的大面积伤口最有益。